December 19, 2025

Zevra Therapeutics, Inc. (ZVRA): A Promising Biotech with 178% Potential Upside and Strong Analyst Confidence

Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a dynamic player in the biotechnology sector, is capturing investor attention with its remarkable growth potential and strong analyst confidence. Headquartered..

Kamada Ltd. (KMDA) Stock Analysis: Unpacking a 111% Potential Upside in the Healthcare Sector

Kamada Ltd. (NASDAQ: KMDA) is garnering significant attention from investors, particularly due to its impressive potential upside of 111.22%. As a key player in the healthcare..

Definitive Healthcare Corp. (DH) Stock Report: Evaluating a 45% Potential Upside Amidst Sector Challenges

Definitive Healthcare Corp. (NASDAQ: DH), a prominent player in the healthcare information services industry, offers a compelling yet complex investment opportunity. With a market cap of..

Tilray Brands, Inc. (TLRY) Stock Analysis: Potential Upside Amidst Healthcare Sector Challenges

Tilray Brands, Inc. (NASDAQ: TLRY) presents a fascinating case for investors, especially those interested in the dynamic healthcare sector. As a key player in the Drug..

Cullinan Therapeutics (CGEM): An Investor Outlook with a Potential 191% Upside

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is turning heads in the biotechnology sector with a promising pipeline of therapies..

Celcuity Inc. (CELC) Stock Analysis: Exploring a Potential 11% Upside in Biotechnology

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, has captured investor attention with its promising pipeline and recent financial metrics suggesting a potential upside of 11.44%...

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: A 29.45% Upside Amidst Biotech Challenges

Ginkgo Bioworks Holdings, Inc. (DNA), a prominent player in the biotechnology industry, stands at a pivotal point for investors as it navigates the complexities of its..

Surmodics, Inc. (SRDX) Stock Report: Navigating Healthcare Innovation Amidst Financial Challenges

Surmodics, Inc. (SRDX) is at the forefront of innovation in the healthcare sector, specifically within the medical devices industry. Headquartered in Eden Prairie, Minnesota, this company..

Abivax SA (ABVX): Investor Outlook Reveals 27.89% Potential Upside Amid Robust Buy Ratings

For investors with an eye on the biotechnology sector, Abivax SA (ABVX) presents an intriguing opportunity. With a market capitalization of $8.96 billion, this Paris-based clinical-stage..

Precigen, Inc. (PGEN) Stock Analysis: Exploring a 103.84% Upside Potential in the Booming Biotech Sector

Precigen, Inc. (NASDAQ: PGEN), a cutting-edge biotechnology company based in Germantown, Maryland, has been gaining attention in the healthcare sector with its innovative approach to gene..

Septerna, Inc. (SEPN) Investor Outlook: A Biotech Gem with Over 9% Upside

Septerna, Inc. (NASDAQ: SEPN) is capturing investor attention with its significant market cap of $1.23 billion and a promising potential upside of 9.66%. Operating in the..

Tourmaline Bio, Inc. (TRML) Stock Analysis: A Biotech Contender with a Breakthrough Focus

Tourmaline Bio, Inc. (TRML), a biotechnology company at the forefront of developing treatments for autoimmune and inflammatory diseases, has recently captured investor attention. Despite its relatively..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: 47% Potential Upside Sparks Investor Interest

Organogenesis Holdings Inc. (NASDAQ: ORGO) is capturing investor attention with a noteworthy 47.31% potential upside, as indicated by the average target price set by analysts. This..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A Strong Buy with 75% Upside Potential

Oruka Therapeutics, Inc. (NASDAQ: ORKA) has captured the attention of investors in the biotechnology sector with its promising pipeline of novel monoclonal antibody therapeutics targeting psoriasis..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Navigating Challenges with a 9.76% Potential Upside

Emergent BioSolutions Inc. (NYSE: EBS), a key player in the healthcare sector, is in the spotlight for its innovative solutions addressing public health threats. With its..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Opportunities in the Healthcare Sector

Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector, is a company that provides essential home health and hospice services across the United States...

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a Significant 185% Potential Upside

LifeMD, Inc. (NASDAQ: LFMD) offers a unique investment opportunity within the healthcare sector, specifically in the burgeoning field of telehealth. With its market capitalization at approximately..

Owens & Minor, Inc. (OMI) Stock Analysis: Navigating the Healthcare Distribution Landscape with an 80% Potential Upside

Owens & Minor, Inc. (NYSE: OMI), a stalwart in the healthcare distribution sector, offers an intriguing prospect for investors with its substantial potential upside of 80.95%,..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Understanding the 79.58% Potential Upside

Relay Therapeutics, Inc. (NASDAQ: RLAY) is attracting attention within the biotechnology sector, not only for its innovative approach to drug discovery but also for its potential..

Cel-Sci Corporation (CVM) Stock Analysis: Unveiling a Biotechnology Giant with 672% Upside Potential

Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology company, stands at a pivotal point with its market cap at $43.96 million and a stock price currently at..

Search

Funds

December 19, 2025

Search

Funds

December 19, 2025

FTSE 100

Funds